April 24, 2025 (Santa Barbara, CA) The Nuclear Medicine Department at Ridley-Tree Cancer Center, now part of Sutter Health, announces greater capabilities to treat prostate cancer using the injectable ...
Treatment for local patients with metastatic prostate cancer may no longer require long trips to Pittsburgh.The UPMC Hillman ...
Treatment with Pluvicto following ARPI resulted in favorable progression and response outcomes in PSMA-positive mCRPR. Among patients with prostate-specific membrane antigen (PSMA)-positive metastatic ...
New indication approximately triples eligible patient population, allowing Pluvicto ® to be used after one androgen receptor pathway inhibitor (ARPI) and now before chemotherapy Pluvicto significantly ...
(RTTNews) - Novartis (NVS) said multiple US real-world studies reinforced earlier use of Pluvicto before chemotherapy in metastatic castration-resistant prostate cancer. Real-world use of Pluvicto ...
Novartis has reported new data to support its drive to expand the label of its radioligand therapy Pluvicto to include ...
FRANKFURT, June 2 (Reuters) - Novartis (NOVN.S), opens new tab said on Monday that its targeted radiotherapy Pluvicto was shown to slow progression of a certain type of prostate cancer, raising the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results